Cristiane Alves Villela-Nogueira , Cristiane Valle Tovo , Nathalie Carvalho Leite , Mário Reis Álvares-da-Silva , Claudia Alexandra Ivantes , Claudia Alves Couto , Giovanni Faria Silva , Edson Roberto Parise , Ana Carolina Cardoso , Natalia Ballassiano Wajsbrot , Luis Fernando Ferreira , Muriel Manica , Gabriela Perdomo Coral , Matheus Michalczuk , Rafael Biesek Novaes , Brian Vinícius Batista Pinheiro , Rosangela Réa , Luciana Costa Faria , Fernando Gomes Romeiro , Leila Priscilla Pinheiro da Silva , Claudia P.M.S. Oliveira
{"title":"巴西代谢性脂肪变性肝病相关的显著和晚期纤维化患病率以及fib-4和振动控制弹性成像的相关准确性——一项国家登记","authors":"Cristiane Alves Villela-Nogueira , Cristiane Valle Tovo , Nathalie Carvalho Leite , Mário Reis Álvares-da-Silva , Claudia Alexandra Ivantes , Claudia Alves Couto , Giovanni Faria Silva , Edson Roberto Parise , Ana Carolina Cardoso , Natalia Ballassiano Wajsbrot , Luis Fernando Ferreira , Muriel Manica , Gabriela Perdomo Coral , Matheus Michalczuk , Rafael Biesek Novaes , Brian Vinícius Batista Pinheiro , Rosangela Réa , Luciana Costa Faria , Fernando Gomes Romeiro , Leila Priscilla Pinheiro da Silva , Claudia P.M.S. Oliveira","doi":"10.1016/j.aohep.2025.101991","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction and Objectives</h3><div>Recent data regarding the prevalence of significant and advanced MASLD-related fibrosis in Brazil is unknown. We aimed to evaluate the prevalence of significant (SF, F≥2) and advanced (AF, F≥F3) fibrosis according to its different geographic regions, and the accuracy of FIB-4 and liver elastography by VCTE (Fibroscan, Echosens, Fr) for the diagnosis of SF and AF respectively.</div></div><div><h3>Patients and Methods</h3><div>This was a sectional study in ten Brazilian University Centers (Southeast, n=6; Northeast, n=1; South, n=3). Demographic, clinic, laboratory, liver stiffness measurement by VCTE (Fibroscan®, Echosens, Fr), and liver biopsy (LB) results were registered. The AUROCs for FIB-4 and VCTE regarding SF and AF were plotted with LB as a reference.</div></div><div><h3>Results</h3><div>2905 patients were included (53% women, 64% white, 51 ± 14 yrs, 44% T2DM) According to LB (n=2122), most form the South (72%; p<0.001), 75% were F0-F1, 12% F2, 9% F3 and 4% F4. Most data from VCTE are from Southeast (n = 1084, 85%). LSM< 8 kPa, between 8 and 12 kPa and ≥ 12 kPa was observed in 44%, 25% and 31% of patients. Most patients from the Southeast region presented a LSM ≥ 12 kPa (p = 0.01). FIB-4 score was <1.3 in 81% of patients. For F3, the AUROC for FIB-4 and LSM were 0.75 (95% CI: 0.70-0.80; p<0.01) and 0.72 (95% CI: 0.68-0.77; p<0.01) respectively and for F2, 0.67 (95% CI: 0.62-0.72; p<0.01) for FIB-4 and 0.64 (95% CI: 0.60-0.69; p<0.01) for VCTE.</div></div><div><h3>Conclusions</h3><div>Most MASLD patients with AF are from the Southeast. VCTE is primarily available in the Sotheast, affecting the stepwise fibrosis stratification of MASLD in other regions and justifying the higher proportion of LB in the South. The accuracy of FIB-4 and liver elastography by Fibroscan® is good for diagnosing AF, but not for SF.</div></div>","PeriodicalId":7979,"journal":{"name":"Annals of hepatology","volume":"30 ","pages":"Article 101991"},"PeriodicalIF":4.4000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"METABOLIC ASSOCIATED STEATOTIC LIVER DISEASE-RELATED SIGNIFICANT AND ADVANCED FIBROSIS' PREVALENCE IN BRAZIL AND THE ASSOCIATED ACCURACY OF FIB-4 AND VIBRATION-CONTROLLED ELASTOGRAPHY - A NATIONAL REGISTER\",\"authors\":\"Cristiane Alves Villela-Nogueira , Cristiane Valle Tovo , Nathalie Carvalho Leite , Mário Reis Álvares-da-Silva , Claudia Alexandra Ivantes , Claudia Alves Couto , Giovanni Faria Silva , Edson Roberto Parise , Ana Carolina Cardoso , Natalia Ballassiano Wajsbrot , Luis Fernando Ferreira , Muriel Manica , Gabriela Perdomo Coral , Matheus Michalczuk , Rafael Biesek Novaes , Brian Vinícius Batista Pinheiro , Rosangela Réa , Luciana Costa Faria , Fernando Gomes Romeiro , Leila Priscilla Pinheiro da Silva , Claudia P.M.S. Oliveira\",\"doi\":\"10.1016/j.aohep.2025.101991\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction and Objectives</h3><div>Recent data regarding the prevalence of significant and advanced MASLD-related fibrosis in Brazil is unknown. We aimed to evaluate the prevalence of significant (SF, F≥2) and advanced (AF, F≥F3) fibrosis according to its different geographic regions, and the accuracy of FIB-4 and liver elastography by VCTE (Fibroscan, Echosens, Fr) for the diagnosis of SF and AF respectively.</div></div><div><h3>Patients and Methods</h3><div>This was a sectional study in ten Brazilian University Centers (Southeast, n=6; Northeast, n=1; South, n=3). Demographic, clinic, laboratory, liver stiffness measurement by VCTE (Fibroscan®, Echosens, Fr), and liver biopsy (LB) results were registered. The AUROCs for FIB-4 and VCTE regarding SF and AF were plotted with LB as a reference.</div></div><div><h3>Results</h3><div>2905 patients were included (53% women, 64% white, 51 ± 14 yrs, 44% T2DM) According to LB (n=2122), most form the South (72%; p<0.001), 75% were F0-F1, 12% F2, 9% F3 and 4% F4. Most data from VCTE are from Southeast (n = 1084, 85%). LSM< 8 kPa, between 8 and 12 kPa and ≥ 12 kPa was observed in 44%, 25% and 31% of patients. Most patients from the Southeast region presented a LSM ≥ 12 kPa (p = 0.01). FIB-4 score was <1.3 in 81% of patients. For F3, the AUROC for FIB-4 and LSM were 0.75 (95% CI: 0.70-0.80; p<0.01) and 0.72 (95% CI: 0.68-0.77; p<0.01) respectively and for F2, 0.67 (95% CI: 0.62-0.72; p<0.01) for FIB-4 and 0.64 (95% CI: 0.60-0.69; p<0.01) for VCTE.</div></div><div><h3>Conclusions</h3><div>Most MASLD patients with AF are from the Southeast. VCTE is primarily available in the Sotheast, affecting the stepwise fibrosis stratification of MASLD in other regions and justifying the higher proportion of LB in the South. The accuracy of FIB-4 and liver elastography by Fibroscan® is good for diagnosing AF, but not for SF.</div></div>\",\"PeriodicalId\":7979,\"journal\":{\"name\":\"Annals of hepatology\",\"volume\":\"30 \",\"pages\":\"Article 101991\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1665268125002169\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of hepatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1665268125002169","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
METABOLIC ASSOCIATED STEATOTIC LIVER DISEASE-RELATED SIGNIFICANT AND ADVANCED FIBROSIS' PREVALENCE IN BRAZIL AND THE ASSOCIATED ACCURACY OF FIB-4 AND VIBRATION-CONTROLLED ELASTOGRAPHY - A NATIONAL REGISTER
Introduction and Objectives
Recent data regarding the prevalence of significant and advanced MASLD-related fibrosis in Brazil is unknown. We aimed to evaluate the prevalence of significant (SF, F≥2) and advanced (AF, F≥F3) fibrosis according to its different geographic regions, and the accuracy of FIB-4 and liver elastography by VCTE (Fibroscan, Echosens, Fr) for the diagnosis of SF and AF respectively.
Patients and Methods
This was a sectional study in ten Brazilian University Centers (Southeast, n=6; Northeast, n=1; South, n=3). Demographic, clinic, laboratory, liver stiffness measurement by VCTE (Fibroscan®, Echosens, Fr), and liver biopsy (LB) results were registered. The AUROCs for FIB-4 and VCTE regarding SF and AF were plotted with LB as a reference.
Results
2905 patients were included (53% women, 64% white, 51 ± 14 yrs, 44% T2DM) According to LB (n=2122), most form the South (72%; p<0.001), 75% were F0-F1, 12% F2, 9% F3 and 4% F4. Most data from VCTE are from Southeast (n = 1084, 85%). LSM< 8 kPa, between 8 and 12 kPa and ≥ 12 kPa was observed in 44%, 25% and 31% of patients. Most patients from the Southeast region presented a LSM ≥ 12 kPa (p = 0.01). FIB-4 score was <1.3 in 81% of patients. For F3, the AUROC for FIB-4 and LSM were 0.75 (95% CI: 0.70-0.80; p<0.01) and 0.72 (95% CI: 0.68-0.77; p<0.01) respectively and for F2, 0.67 (95% CI: 0.62-0.72; p<0.01) for FIB-4 and 0.64 (95% CI: 0.60-0.69; p<0.01) for VCTE.
Conclusions
Most MASLD patients with AF are from the Southeast. VCTE is primarily available in the Sotheast, affecting the stepwise fibrosis stratification of MASLD in other regions and justifying the higher proportion of LB in the South. The accuracy of FIB-4 and liver elastography by Fibroscan® is good for diagnosing AF, but not for SF.
期刊介绍:
Annals of Hepatology publishes original research on the biology and diseases of the liver in both humans and experimental models. Contributions may be submitted as regular articles. The journal also publishes concise reviews of both basic and clinical topics.